Online citations, reference lists, and bibliographies.
← Back to Search

Phase II Clinical Trial Of Amatuximab, A Chimeric Antimesothelin Antibody With Pemetrexed And Cisplatin In Advanced Unresectable Pleural Mesothelioma

R. Hassan, H. L. Kindler, T. Jahan, L. Bazhenova, M. Reck, A. Thomas, I. Pastan, J. Parno, D. J. O'Shannessy, P. Fatato, J. D. Maltzman, B. A. Wallin

Cite This
Download PDF
Analyze on Scholarcy
Share